SEC 13F Intelligence

Altium Capital Management LLC / HRMY

Altium Capital Management LLC’s Harmony Biosciences Hldgs In Position

Does Altium Capital Management LLC own Harmony Biosciences Hldgs In (HRMY)? Not currently — the last reported position was 117.0K shares worth $4M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q3 2023
Shares
117.0K
% of Portfolio
+2.00%
Quarters Held
4
position exited

Position History HRMY

Reported value by quarter
Q2 ’22: $2MQ2 ’22Q1 ’23: $979,500Q1 ’23Q2 ’23: $5MQ2 ’23Q3 ’23: $4MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2023117.0K$4M+2.00%
Q2 2023149.9K$5M+3.99%
Q1 202330.0K$979,500+0.54%
Q2 202250.0K$2M+0.98%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of HRMY.